Close menu




November 18th, 2021 | 12:07 CET

RWE, Nordex, Water Ways, JinkoSolar: These shares are just starting to blossom

  • agritech
Photo credits: pixabay.com

Sustainability pays off! Even utility RWE believes that the EUR 50 billion the Company plans to invest in transforming its corporate structure is capital well spent and expects profit increases of up to 10% annually in the course of the measures. Since operating sites also determine whether a company's sustainability account is in the green or not, photovoltaic suppliers are also likely to benefit from climate change. Industrial companies will also fare better in the long term with renewable energy - companies like Nordex are already looking forward to it. This article explains where opportunities are waiting around climate change and whether there are still niches that have received little attention from the market.

time to read: 3 minutes | Author: Nico Popp
ISIN: RWE AG INH O.N. | DE0007037129 , NORDEX SE O.N. | DE000A0D6554 , Water Ways Technologies | CA9411881043 , JINKOSOLAR ADR/4 DL-00002 | US47759T1007

Table of contents:


    Nordex: Good business, weak margin

    Wind turbine manufacturer Nordex is well positioned for the future. Only some time ago, the Company converted its turbines to a new platform, promising more profitability. The Company is also perfectly equipped for the trend towards ever-larger wind turbines with the largest series wind turbine in the world. In the first half of the year, Nordex installed more new turbines than ever before. The main focus of its activities is in Europe. While sales rose by around 31.7% in the first half of the year, the margin only increased to 2.5%. That shows: Even with the more profitable Delta 4000 platform, Nordex is under cost pressure.

    Rising raw material prices for steel, copper and also carbon have a significant impact on this. To remain competitive in the long term, Nordex is working on technological innovations, focusing primarily on rotor blades and turbines. To increase the number of units, it is also apparent to shift the focus from Europe to other regions. Nordex has chosen India as its target: renewable energies are less widespread there, but demand is increasing. Nordex shares have lost more than 6% over the past year, and the low profitability is not going down well in the market. Now the focus is on the India plans.

    Water Ways Technologies: Save water, earn returns

    A company that does good business in both developed and emerging markets is the small-cap Water Ways Technologies. Measured by market capitalization, the Company, which has a market capitalization of around EUR 30 million, is of course not comparable to Nordex. But the small size and the associated lean structure also have advantages. But first things first: Water Ways Technologies is an agrotech company dedicated to the efficient use of water. Water is scarce in many regions of the world. Analysts, such as Charles Iceland of the World Resources Institute, even predict that humanity will wage wars over the precious liquid in the 21st century. The majority of water is currently wasted in agriculture. Here is where Water Ways Technologies comes in, offering complete solutions based on sensors and apps that help use water in a targeted manner and ultimately save it.

    The business model is hitting a nerve in the market: in the first half of the year, the Company generated revenue of CAD 12.1 million and EBITDA of CAD 832,000. The Company is active worldwide and landed a record order in China a few months ago with a volume of CAD 4 million. More recently, it followed up with additional orders around an automated system for irrigation and fertilization. Water Ways is benefiting in this area from high demand from the cannabis sector, which is growing strongly in many countries in the wake of liberalizations. Water Ways Technologies' stock has been building momentum in recent days. Recent history shows that the share is good for jumping revaluations. That is due to the low valuation and the importance that new orders have in this context.

    JinkoSolar: Good prices are not everything

    New orders also beckon for JinkoSolar - after all, the Company is well positioned and convinces with low prices at good quality. In recent weeks, the share came under a bit of pressure in the wake of China's concerns. In the long term, however, photovoltaic and solar energy should remain a dynamic growth area. Since China has secured raw materials in recent years, manufacturers from the Middle Kingdom, in particular, could gain further market share in a phase of a general shortage of basic materials in the industry. However, one risk for JinkoSolar lies in the increasing consideration of supply chains when assessing how sustainable products are. Solar panels made from non-sustainable mined raw materials could soon be penalized and thus be less in demand from companies that need to pay attention to their carbon footprint.


    While Nordex has a good business but earns relatively little from it, it looks better for JinkoSolar. Both companies are still often the first choice for investors regarding wind or solar energy - despite all the problems and risks. An insider tip so far is the second-tier stock of Water Ways Technologies. Saving water makes sense, especially in agriculture. Orders from China and Israel show that the business model is well received around the world.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by André Will-Laudien on May 7th, 2026 | 08:25 CEST

    Moving Ahead with Strong Concepts and Easing Tensions in the Middle East! MustGrow, K+S, Evotec, and Novo Nordisk in Focus

    • agritech
    • fertilizer
    • chemicals
    • Biotechnology
    • biologics
    • geopolitics

    Created and published on behalf of MustGrow Biologics Corp.

    What a headline: An agreement between the US and Iran – markets up 2% in just one minute! It can happen that fast. For investors, this is welcome news, as a de-escalation in the Iran conflict would significantly ease global supply chains and reduce pressure on critical transport routes. In particular, the Strait of Hormuz would lose some of its significance as a geopolitical risk factor, potentially stabilizing global flows of goods and energy. Easing tensions are also likely to lower transport costs again, shorten delivery times, and dampen price volatility. For companies in the food, healthcare, and agricultural technology sectors, this creates greater planning certainty and new growth opportunities. MustGrow Biologics and K+S could benefit from more stable agricultural markets, while Evotec and Novo Nordisk may gain additional tailwinds in a calmer healthcare environment. Investors are increasingly turning to stocks that promise sustainable growth and reliable returns in a more stable market setting. The key question now: will volatility finally decline as well?

    Read

    Commented by Armin Schulz on May 5th, 2026 | 07:10 CEST

    How to Capitalize on Two of the Greatest Crises of Our Time – Thanks to Novo Nordisk, MustGrow Biologics, and Bayer

    • biologics
    • agritech
    • fertilizer
    • Agriculture
    • chemicals

    Created and published on behalf of MustGrow Biologics Corp.

    While the world battles an obesity epidemic that has turned Novo Nordisk into a cash cow, a potential conflict with Iran threatens to tear apart global agricultural supply chains. More than 2.5 billion people are overweight, while war-induced fertilizer shortages could destroy crops. Two seemingly contradictory crises collide—pharmaceutical solutions for obesity on one side, biological crop protection products against famine on the other. It is precisely in this tension that three companies, each pursuing different approaches, are operating: Novo Nordisk, MustGrow Biologics, and Bayer.

    Read

    Commented by Nico Popp on April 30th, 2026 | 07:30 CEST

    Food Crisis on the Horizon? Nutrien and Nestlé on Edge, MustGrow Biologics Offers Solutions

    • Agriculture
    • agritech
    • biologics
    • mustard
    • fertilizer
    • geopolitics

    Created and published on behalf of MustGrow Biologics Corp.

    The agricultural sector is currently experiencing an unprecedented crisis, triggered by pervasive geopolitical tensions and the Strait of Hormuz blockade. The latter development, in particular, has exposed the Achilles' heel of modern agriculture: the extreme dependence on fossil fuels for fertilizer production and the fragility of global just-in-time supply chains. Since about 20% of the world's crude oil and liquefied natural gas (LNG) flows through this strait, the blockade not only raises energy costs but also directly threatens nitrogen fertilizer production, for which natural gas is the primary cost driver. If fertilizer becomes more expensive, fields could lie fallow, leading to a decline in food production. This could even lead to hunger, particularly in poorer regions of the world. Fertilizer must be applied to fields in a timely manner to be effective. In this environment, established giants like Nutrien and Nestlé must radically optimize their business models, while players such as MustGrow Biologics are gaining importance as drivers of innovation.

    Read